body > *:not(noscript) { display: none !important; } noscript { display: block !important; } .no-js-warning { display: flex !important; min-height: 100vh; align-items: center; justify-content: center; padding: 20px; background: #f8f9fa; text-align: center; } .no-js-card { max-width: 500px; padding: 30px; border-radius: 12px; background: white; box-shadow: 0 10px 30px rgba(0,0,0,0.08); font-family: Arial, sans-serif; } .no-js-card h1 { margin-bottom: 10px; }

JavaScript Required

JavaScript is required for this website to work correctly and provide a smooth user experience. Please enable JavaScript in your browser, then refresh the page.

Top story

The Global Pharma Merger and Acquisition Landscape

Read full story

GSK forges pact with Empirico for respiratory siRNA in $745m deal

Pharmaceutical Technology

By Annabel Kartal Allen - Wed, 29 Oct 2025

Japan’s MHLW grants orphan status to Kyowa and Orchard’s MLD therapy

Pharmaceutical Technology

By gullapalli - Wed, 29 Oct 2025

Aldeyra reshuffles pipeline, culling asset despite Phase II success

Pharmaceutical Technology

By Abigail Beaney - Wed, 29 Oct 2025

Lifecore and PolyPeptide link for US peptide manufacturing

Pharmaceutical Technology

By sdebbarma - Wed, 29 Oct 2025

ESMO 2025: Data, decisions, and the future of oncology

Pharmaceutical Technology

By Fi Forrest - Wed, 29 Oct 2025

FDA rejects Regeneron’s pre-filled Eylea HD syringes amid filling facility woes

Pharmaceutical Technology

By Robert Barrie - Wed, 29 Oct 2025

FDA Shake-Up: Vinay Prasad Exits Amid Tumult in Biologics Oversight

Pharmaceutical Technology

Wed, 30 Jul 2025

Industry Outlook 2025: European Geopolitical Impact on Pharma

Pharmaceutical Technology

Wed, 30 Apr 2025

FDA Grants Fast Track Designation to Q32 Bio Treatment for Alopecia Areata

Pharmaceutical Technology

Wed, 30 Apr 2025